SCHEMBL25781990

SCHEMBL25781990

Cn1nccc1-c1nc2cccnc2[nH]1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
COMT P21964 1/20 0.39
KDM4E B2RXH2 3/20 0.37
NPC1 O15118 3/20 0.37
NPSR1 Q6W5P4 2/20 0.37
RECQL P46063 1/20 0.37
GRM4 Q14833 2/20 0.36
LATS1 O95835 4/20 0.35
LATS2 Q9NRM7 2/20 0.35
ROCK2 O75116 1/20 0.34
ROCK1 Q13464 1/20 0.34
CDC42BPB Q9Y5S2 1/20 0.34
BRD4 O60885 1/20 0.34
LMNA P02545 2/20 0.34
RAB9A P51151 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
ALDH1A1 P00352 1/20 0.34
CYP2D6 P10635 2/20 0.34
MET P08581 1/20 0.34
PORCN Q9H237 1/20 0.34
ATR Q13535 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2674607 0.78 NPC1 (0.60) KDM4ENPC1NPSR1RECQLLMNA
SCHEMBL4048955 0.78 METAP2 (0.47) COMTKDM4ENPC1GRM4LATS1
SCHEMBL15633796 0.78 NPC1 (0.46) KDM4ENPC1NPSR1LMNARAB9A
SCHEMBL25293136 0.77 COMT (0.36) COMTKDM4ELATS1LATS2ROCK1
SCHEMBL14224799 0.77 KDM4E (0.38) KDM4ENPC1NPSR1RECQLLMNA
SCHEMBL14224790 0.74 KDM4E (0.37) KDM4ENPC1NPSR1RECQLLMNA
SCHEMBL31440145 0.74 EPHX2 (0.63) KDM4EBRD4CYP2D6CYP1A2CYP2C9
SCHEMBL25781276 0.73 RIPK1 (0.50) COMTCDK1
Hydrochloric Acid SCHEMBL30669801 0.72 EPHX2 (0.62) KDM4EBRD4CYP2D6CYP1A2CYP2C9
SCHEMBL279584 0.71 PARP1 (0.44) KDM4ENPC1RAB9ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023168686-A1 SUBSTITUTED CYCLOPENTANES AS CDK2 INHIBITORS QILU REGOR THERAPEUTICS INC. (CN) 2023-09-14 WO disclosed
WO-2023116884-A1 CDK2 INHIBITORS AND USE THEREOF QILU REGOR THERAPEUTICS INC. (CN) 2023-06-29 WO disclosed